FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
Geron Corp (NASDAQ: GERN) reported Q4 EPS of ($0.15), $0.05 better than the analyst estimate of ($0.20).
2019 was a pivotal year for Geron as we completed the imetelstat program transition, assembled an impressive in-house team with a proven track record in drug development, and advanced imetelstat... More

